Celltrion USA signs agreement with Express Scripts for its therapy for autoimmune diseases including the first FDA-approved subcutaneous infliximab ZYMFENTRA™

Posted on by

JERSEY CITY, N.J., April 28, 2024 /PRNewswire/ — Celltrion USA announced today that it has signed an agreement with Express Scripts, one of the nation’s leading pharmacy benefit managers (PBMs) negotiating on behalf of health plans covering more than 100 million people. The agreement,…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.